Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Return on Equity (2016 - 2026)

Pharma-Bio Serv's Return on Equity history spans 14 years, with the latest figure at 0.01% for Q1 2026.

  • For Q1 2026, Return on Equity rose 3.0% year-over-year to 0.01%; the TTM value through Jan 2026 reached 0.01%, up 3.0%, while the annual FY2025 figure was 0.01%, 4.0% up from the prior year.
  • Return on Equity reached 0.01% in Q1 2026 per PBSV's latest filing, up from 0.01% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.1% in Q3 2023 to a low of 0.25% in Q3 2022.
  • Average Return on Equity over 5 years is 0.02%, with a median of 0.01% recorded in 2025.
  • Peak YoY movement for Return on Equity: crashed -38bps in 2022, then surged 35bps in 2023.
  • A 5-year view of Return on Equity shows it stood at 0.06% in 2022, then surged by 32bps to 0.08% in 2023, then tumbled by -170bps to 0.06% in 2024, then soared by 84bps to 0.01% in 2025, then rose by 16bps to 0.01% in 2026.
  • Per Business Quant, the three most recent readings for PBSV's Return on Equity are 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025).